top of page
Member News
Search
info787351
Jan 23, 20122 min read
BioRelix Inc. Secures $500,000 Investment from Connecticut Innovations
Antibiotics developer utilizes novel riboswitch-based drug discovery platform Connecticut Innovations (CI), the state’s quasi-public...
8 views0 comments
info787351
Oct 13, 20113 min read
Axerion Therapeutics Inc. Receives $400,000 Follow-on Investment from Connecticut Innovations
New Haven-based biotech company advances innovative treatments for neurological injuries and diseases Connecticut Innovations (CI), the...
2 views0 comments
We Need Your Support Today!
bottom of page